2BB score and signals
Insight Molecular Diagnostics Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 12 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 100 | Very High |
Company facts
| Headquarters | Nashville, Tennessee, United States |
| Founded | 2009 |
| Employees | 57 |
| 52-week range | $2.33 – $8.51 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-24 | — | -0.2387 | — | $477,156.00 |
| 2026-11-05 | — | -0.2407 | — | $249,084.00 |
| 2026-08-10 | — | -0.2491 | — | $446,250.00 |
| 2026-05-11 | — | -0.204 | — | $528,360.00 |
2BBBullish & Bearish